{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:42:42Z","timestamp":1792975362309,"version":"4.5.0"},"reference-count":87,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&amp;D Program of China","doi-asserted-by":"publisher","award":["2022YFC2502700"],"award-info":[{"award-number":["2022YFC2502700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Biological sex and gender factors significantly influence the pathogenesis, progression, and treatment response in hematologic malignancies. This comprehensive review examines sex-specific differences in acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, and multiple myeloma through systematic analysis of the peer-reviewed literature published between 2014\u20132024 and identified through structured searches of PubMed, Web of Science, and MEDLINE databases. Epidemiological data demonstrate higher disease incidence (57% male vs. 43% female in MM, 63% male vs. 37% female in AML hospitalizations for ages 18\u201339) and inferior outcomes in male patients across malignancy types (5-year relative survival rates of 48.8% vs. 60.4% in females with AML), while female patients exhibit superior survival despite experiencing greater treatment-related toxicities. Our analysis reveals consistent sex-specific patterns in molecular mechanisms, including distinct mutational profiles, differences in immune system function, and sex-based pharmacokinetic variations that collectively suggest the necessity for sex-differentiated treatment approaches. The review identifies reproducible patterns across diseases, particularly in cytogenetic and molecular characteristics, with females demonstrating favorable prognostic mutations in leukemias and higher rates of chromosomal abnormalities in multiple myeloma. Despite these identifiable patterns, significant knowledge gaps persist regarding the underlying mechanisms of sex-based outcome differences. Incorporating sex and gender considerations into precision medicine frameworks represents a critical advancement toward optimizing treatment strategies and improving clinical outcomes for patients with hematologic malignancies.<\/jats:p>","DOI":"10.3390\/curroncol32040204","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T10:59:59Z","timestamp":1743505199000},"page":"204","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Sex and Gender in Myeloid and Lymphoblastic Leukemias and Multiple Myeloma: From Molecular Mechanisms to Clinical Outcomes"],"prefix":"10.3390","volume":"32","author":[{"given":"Mohammad Amin","family":"Ansarian","sequence":"first","affiliation":[{"name":"Medical College, Xi\u2019an Jiaotong University, Xi\u2019an 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Fatahichegeni","sequence":"additional","affiliation":[{"name":"Medical College, Xi\u2019an Jiaotong University, Xi\u2019an 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7925-2774","authenticated-orcid":false,"given":"Xiaoning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an 710061, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/joim.13508","article-title":"Application of precision medicine in clinical routine in haematology\u2014Challenges and opportunities","volume":"292","author":"Cavelier","year":"2022","journal-title":"J. Intern. Med."},{"key":"ref_2","first-page":"1004","article-title":"Genomics-based precision medicine in hematology\/oncology","volume":"62","author":"Maeda","year":"2021","journal-title":"[Rinsho Ketsueki] Jpn. J. Clin. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/joim.13697","article-title":"Novel precision medicine approaches and treatment strategies in hematological malignancies","volume":"294","author":"Rosenquist","year":"2023","journal-title":"J. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/annonc\/mdz414","article-title":"Gender Medicine and Oncology: Report and consensus of an ESMO Workshop","volume":"30","author":"Wagner","year":"2019","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jamainternmed.2019.7194","article-title":"Clinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All: A Review","volume":"180","author":"Bartz","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_6","first-page":"e66","article-title":"Sex differences in outcomes in multiple myeloma","volume":"192","author":"Derman","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2017-06-735753","article-title":"Introduction to a review series on precision hematology","volume":"130","author":"Ebert","year":"2017","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1182\/blood-2021-146604","article-title":"Sex Differences in Lymphoma Incidence and Excess Mortality By Subtype: A Comprehensive National Study","volume":"138","author":"Radkiewicz","year":"2021","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1007\/s10508-024-02933-2","article-title":"Do Sex and Gender Have Separate Identities?","volume":"53","author":"Quintana","year":"2024","journal-title":"Arch. Sex. Behav."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Malik, M. (2020). The distinction between the terms sex and gender. Sex and Cardiac Electrophysiology, Academic Press.","DOI":"10.1016\/B978-0-12-817728-0.00001-2"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"vom Steeg, L.G., and Klein, S.L. (2016). SeXX Matters in Infectious Disease Pathogenesis. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005374"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"osad003","DOI":"10.1093\/exposome\/osad003","article-title":"Exposomics as a tool to investigate differences in health and disease by sex and gender","volume":"3","author":"Bucher","year":"2023","journal-title":"Exposome"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"H781","DOI":"10.1152\/ajpheart.00994.2013","article-title":"Why are sex and gender important to basic physiology and translational and individualized medicine?","volume":"306","author":"Miller","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Nielsen, M.W., Stefanick, M.L., Peragine, D., Neilands, T.B., Ioannidis, J.P.A., Pilote, L., Prochaska, J.J., Cullen, M.R., Einstein, G., and Klinge, I. (2020). Gender-related variables for health research. Biol. Sex Differ., 12.","DOI":"10.1101\/2020.09.17.20196824"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jnr.23963","article-title":"Sex differences, gender and addiction","volume":"95","author":"Becker","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105442","DOI":"10.1016\/j.yhbeh.2023.105442","article-title":"Considering hormones as sex- and gender-related factors in biomedical research: Challenging false dichotomies and embracing complexity","volume":"156","author":"Williams","year":"2023","journal-title":"Horm. Behav."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.yhbeh.2006.09.005","article-title":"Competition and testosterone","volume":"50","author":"Edwards","year":"2006","journal-title":"Horm. Behav."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"72356","DOI":"10.18632\/oncotarget.12050","article-title":"Sex chromosome loss and the pseudoautosomal region genes in hematological malignancies","volume":"7","author":"Weng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10245332.2017.1375063","article-title":"Sex chromosome changes in leukemia: Cytogenetics and molecular aspects","volume":"23","author":"Shahrabi","year":"2018","journal-title":"Hematology"},{"key":"ref_20","first-page":"185","article-title":"Sex differences in normal and malignant hematopoiesis","volume":"4","author":"Cui","year":"2022","journal-title":"Blood Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/leu.2017.148","article-title":"Why are hematopoietic stem cells so \u2018sexy\u2019? on a search for developmental explanation","volume":"31","author":"Ratajczak","year":"2017","journal-title":"Leukemia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.seminoncol.2016.10.003","article-title":"Genetic predisposition to leukemia and other hematologic malignancies","volume":"43","author":"Feurstein","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood-2016-09-687889","article-title":"GATA factor mutations in hematologic disease","volume":"129","author":"Crispino","year":"2017","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"key":"ref_25","first-page":"21","article-title":"The Influence of Sex Hormones and X Chromosome in Immune Responses","volume":"441","author":"Anesi","year":"2023","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2017-02-734541","article-title":"Diagnosis and classification of hematologic malignancies on the basis of genetics","volume":"130","author":"Taylor","year":"2017","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21106\/ijtmrph.402","article-title":"Sex and Age-Based Differences in Adult Acute Myeloid Leukemia Hospitalizations in the United States, 2009\u20132018","volume":"6","author":"Dongarwar","year":"2022","journal-title":"Int. J. Transl. Med. Res. Public Health"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1186\/s12967-024-05990-2","article-title":"Sex differences in disease: Sex chromosome and immunity","volume":"22","author":"Feng","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.59298\/ROJPHM\/2024\/411924","article-title":"Sex Disparities in Cancer Immunotherapy: A Review","volume":"4","author":"Evelyn","year":"2024","journal-title":"Res. Output J. Public Health Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.20.00475","article-title":"Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy","volume":"39","author":"Khaldoyanidi","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_32","first-page":"2167-0501","article-title":"Sex and Major Molecular Response to Imatinib Treatment for Patients with Chronic Myeloid Leukemia","volume":"8","author":"Nachi","year":"2019","journal-title":"Biochem. Pharmacol. Open Access"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/FTD.0000000000000440","article-title":"Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men","volume":"39","author":"Belsey","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4062\/biomolther.2018.103","article-title":"Sex Differences in Cancer: Epidemiology, Genetics and Therapy","volume":"26","author":"Kim","year":"2018","journal-title":"Biomol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100152","DOI":"10.1016\/j.crphar.2022.100152","article-title":"Sex differences in drug effects and\/or toxicity in oncology","volume":"4","author":"Rakshith","year":"2023","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/978-3-642-30726-3_19","article-title":"Sex differences in the drug therapy for oncologic diseases","volume":"214","author":"Schmetzer","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_37","first-page":"55","article-title":"Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia","volume":"19","author":"Herrero","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e1961","DOI":"10.1002\/cnr2.1961","article-title":"Awareness of the impact of sex and gender in the disease risk and outcomes in hematology and medical oncology\u2014A survey of Swiss clinicians","volume":"7","author":"Darphin","year":"2024","journal-title":"Cancer Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e000770","DOI":"10.1136\/esmoopen-2020-000770","article-title":"Sex differences in cancer chemotherapy effects, and why we need to reconsider BSA-based dosing of chemotherapy","volume":"5","author":"Wagner","year":"2020","journal-title":"ESMO Open"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"104002","DOI":"10.1016\/j.esmoop.2024.104002","article-title":"Sex differences in the pharmacokinetics of anticancer drugs: A systematic review","volume":"9","author":"Delahousse","year":"2024","journal-title":"ESMO Open"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canep.2016.03.011","article-title":"Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK\u2019s population-based Haematological Malignancy Research Network 2004\u201315","volume":"42","author":"Roman","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-020-00908-z","article-title":"The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: Estimates based on the global burden of disease study 2017","volume":"13","author":"Yi","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Inaba, H., and Pui, C.-H. (2021). Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia. J. Clin. Med., 10.","DOI":"10.3390\/jcm10091926"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2020-136609","article-title":"Sex-Based Disparities in Outcome in Childhood Acute Lymphoblastic Leukemia (ALL): A Children\u2019s Oncology Group (COG) Report","volume":"136","author":"Gupta","year":"2020","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00411-013-0507-4","article-title":"Sex differences in the incidence of chronic myeloid leukemia","volume":"53","author":"Radivoyevitch","year":"2014","journal-title":"Radiat. Environ. Biophys."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/s41375-018-0341-4","article-title":"The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview","volume":"33","author":"Baccarani","year":"2019","journal-title":"Leukemia"},{"key":"ref_48","first-page":"100373","article-title":"Chronic-phase chronic myeloid leukemia: Incidence of BCR\/ABL transcript and its correlation with presenting features, response to treatment, and survival","volume":"20","author":"Laabidi","year":"2023","journal-title":"Leuk. Res. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41375-023-02068-8","article-title":"Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)","volume":"38","author":"Ozga","year":"2023","journal-title":"Leukemia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/1097-0142(19891001)64:7<1437::AID-CNCR2820640714>3.0.CO;2-1","article-title":"Correlations between acute lymphoid leukemia (ALL) immunophenotype and clinical and laboratory data at presentation. A study of 350 patients","volume":"64","author":"Garand","year":"1989","journal-title":"Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V91.11.3995","article-title":"Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia","volume":"91","author":"Faderl","year":"1998","journal-title":"Blood"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e5300","DOI":"10.1097\/MD.0000000000005300","article-title":"A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants","volume":"95","author":"Singh","year":"2016","journal-title":"Medicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2141.1997.d01-1982.x","article-title":"Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period","volume":"96","author":"Savage","year":"1997","journal-title":"Br. J. Haematol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.leu.2403756","article-title":"Gender aspects in chronic myeloid leukemia: Long-term results from randomized studies","volume":"19","author":"Berger","year":"2005","journal-title":"Leukemia"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1542\/peds.2004-2473","article-title":"Clinical and Biological Features at Diagnosis in 40 Children With Chronic Myeloid Leukemia","volume":"116","author":"Millot","year":"2005","journal-title":"Pediatrics"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1182\/bloodadvances.2022007544","article-title":"High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML","volume":"6","author":"Larkin","year":"2022","journal-title":"Blood Adv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/blood-2024-204342","article-title":"Sex-Related Differences in CML Outcomes in a Real-World Prospective Registry (GQR LMC-NMP)","volume":"144","author":"Beaudet","year":"2024","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.25303\/1901rjbt049054","article-title":"Haematological and Clinical Characterization of Chronic Myeloid Leukemia","volume":"19","author":"Shivani","year":"2023","journal-title":"Res. J. Biotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","article-title":"Sex-Specific Cardiovascular Risks of Cancer and Its Therapies","volume":"130","author":"Wilcox","year":"2022","journal-title":"Circ. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1038\/s41467-024-46945-x","article-title":"Outcome differences by sex in oncology clinical trials","volume":"15","author":"Kammula","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Iguchi, N., Hecht, S.L., Gao, D., Wilcox, D.T., Malykhina, A.P., and Cost, N.G. (2022). Sexual dimorphic impacts of systemic vincristine on lower urinary tract function. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-08585-3"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e28040","DOI":"10.1002\/pbc.28040","article-title":"Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia","volume":"67","author":"Finch","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"pkac026","DOI":"10.1093\/jncics\/pkac026","article-title":"Sex-Based Differences in Functional Brain Activity During Working Memory in Survivors of Pediatric Acute Lymphoblastic Leukemia","volume":"6","author":"Gandy","year":"2022","journal-title":"JNCI Cancer Spectr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/ejh.13293","article-title":"Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population-based study","volume":"103","author":"Lauseker","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clml.2021.04.013","article-title":"Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial","volume":"21","author":"Bird","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1182\/blood-2019-122512","article-title":"The Frequency of Cytogenetic and FISH Abnormalities Is Higher in Female Than in Male Multiple Myeloma (MM) Patients","volume":"134","author":"Watson","year":"2019","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1159\/000525493","article-title":"Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort","volume":"45","author":"Brioli","year":"2022","journal-title":"Oncol. Res. Treat."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jha2.470","article-title":"Gender disparities in multiple myeloma publications","volume":"3","author":"Dweik","year":"2022","journal-title":"EJHaem"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"A470","DOI":"10.21276\/APALM.1245","article-title":"Multiple Myeloma: Clinico-hematological profile in a tertiary care hospital: A three years study","volume":"4","author":"Kaushik","year":"2017","journal-title":"Ann. Pathol. Lab. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bmt.1704861","article-title":"The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: Reduced relapse risk in female to male transplants","volume":"35","author":"Gahrton","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000478265","article-title":"Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center Experience","volume":"93","author":"Posch","year":"2017","journal-title":"Oncology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.3390\/cancers16193364","article-title":"Gender-Specific Prognostic Impact of Treosulfan Levels in High-Dose Chemotherapy for Multiple Myeloma","volume":"16","author":"Heini","year":"2024","journal-title":"Cancers"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e19524","DOI":"10.1200\/JCO.2024.42.16_suppl.e19524","article-title":"Exploring gender-based decision-making differences among patients with relapsed\/refractory multiple myeloma","volume":"42","author":"Arnett","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1080\/10428194.2022.2038378","article-title":"Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapies","volume":"63","author":"Siddiqui","year":"2022","journal-title":"Leuk. Lymphoma"},{"key":"ref_75","first-page":"299","article-title":"An Integrative Review of Sex Differences in Quality of Life and Symptoms Among Survivors of Hematologic Malignancies","volume":"50","author":"Nodzon","year":"2023","journal-title":"Oncol. Nurs. Forum"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/jwh.2012.3972","article-title":"Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines","volume":"23","author":"Manteuffel","year":"2014","journal-title":"J. Women\u2019s Health"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2017-04-778225","article-title":"Racial and ethnic disparities in hematologic malignancies","volume":"130","author":"Kirtane","year":"2017","journal-title":"Blood"},{"key":"ref_78","first-page":"1","article-title":"Understanding and Addressing Disparities in Patients with Hematologic Malignancies: Approaches for Clinicians","volume":"41","author":"Flowers","year":"2021","journal-title":"Am. Soc. Clin. Oncol. Educ. Book. Am. Soc. Clin. Oncol. Annu. Meet."},{"key":"ref_79","first-page":"1","article-title":"Abstracts of the 13th Annual Conference of the American Psychosocial Oncology Society, 3\u20135 March 2016, San Diego, California","volume":"25","author":"Loscalzo","year":"2016","journal-title":"Psycho-Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Liu, L., Yang, Y., Wang, Z.-Y., Wu, H., Wang, Y., and Wang, L. (2015). Prevalence and Positive Correlates of Posttraumatic Stress Disorder Symptoms among Chinese Patients with Hematological Malignancies: A Cross-Sectional Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145103"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/apjon.apjon_41_20","article-title":"Unmet Supportive Care Needs of Patients with Hematological Malignancies: A Systematic Review","volume":"8","author":"Tsatsou","year":"2020","journal-title":"Asia-Pac. J. Oncol. Nurs."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1002\/cncr.27432","article-title":"Gender representation of cancer patients in medical treatment and psychosocial survivorship research","volume":"118","author":"Hoyt","year":"2012","journal-title":"Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1002\/cam4.2280","article-title":"Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non-small cell lung cancer","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med."},{"key":"ref_84","first-page":"e344","article-title":"The Glass Wall: Gendered Authorship Disparities in in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma","volume":"24","author":"Khaliq","year":"2023","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.amjms.2019.11.005","article-title":"Gender Disparity in Authorship of Peer-Reviewed Medical Publications","volume":"360","author":"Bernardi","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1158\/1055-9965.EPI-11-0157","article-title":"Gender Disparities in the Tumor Genetics and Clinical Outcome of Multiple Myeloma","volume":"20","author":"Boyd","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41408-018-0118-z","article-title":"Biological determinants of health disparities in multiple myeloma","volume":"8","author":"Smith","year":"2018","journal-title":"Blood Cancer J."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/4\/204\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:06:22Z","timestamp":1760029582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/4\/204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":87,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["curroncol32040204"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32040204","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]}}}